Kasia Gustaw-Rothenberg, MD, PhD
Affiliations: | Institute of Agricultural Medicine | Case Western Reserve University, Cleveland Heights, OH, United States |
Website:
http://www.linkedin.com/pub/kasia-gustaw/12/157/5Google:
"Kasia Gustaw-Rothenberg"Bio:
http://www.linkedin.com/pub/kasia-gustaw/12/157/5
http://www.linkedin.com/pub/kasia-gustaw-rothenberg/12/157/5/pl
http://174.129.244.7/96432851.html
Cross-listing: Neurotree
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Blach-Olszewska Z, Zaczynska E, Gustaw-Rothenberg K, et al. (2015) The Innate Immunity in Alzheimer Disease- Relevance to Pathogenesis and Therapy. Current Pharmaceutical Design. 21: 3582-8 |
Raszewski G, Chwedorowicz R, Chwedorowicz A, et al. (2015) Homocysteine, antioxidant vitamins and lipids as biomarkers of neurodegeneration in Alzheimer’s disease versus non-Alzheimer’s dementia Journal of Pre-Clinical and Clinical Research. 9: 105-108 |
Blach-Olszewska Z, Zaczynska E, Gustaw-Rothenberg K, et al. (2015) The innate immunity in alzheimer disease-relevance to pathogenesis and therapy Current Pharmaceutical Design. 21: 3582-3588 |
Lerner AJ, Gustaw-Rothenberg K, Smyth S, et al. (2012) Retinoids for treatment of Alzheimer's disease. Biofactors (Oxford, England). 38: 84-9 |
Stone JG, Casadesus G, Gustaw-Rothenberg K, et al. (2011) Frontiers in Alzheimer's disease therapeutics. Therapeutic Advances in Chronic Disease. 2: 9-23 |
Gustaw-Rothenberg K, Kowalczuk K, Stryjecka-Zimmer M. (2010) Lipids' peroxidation markers in Alzheimer's disease and vascular dementia. Geriatrics & Gerontology International. 10: 161-6 |
Gustaw-Rothenberg K, Lerner A, Bonda DJ, et al. (2010) Biomarkers in Alzheimer's disease: past, present and future. Biomarkers in Medicine. 4: 15-26 |
Gustaw-Rothenberg KA, Siedlak SL, Bonda DJ, et al. (2010) Dissociated amyloid-beta antibody levels as a serum biomarker for the progression of Alzheimer's disease: a population-based study. Experimental Gerontology. 45: 47-52 |
Bonda DJ, Wang X, Gustaw-Rothenberg KA, et al. (2009) Mitochondrial Drugs for Alzheimer Disease. Pharmaceuticals (Basel, Switzerland). 2: 287-298 |
Lee HP, Casadesus G, Zhu X, et al. (2009) All-trans retinoic acid as a novel therapeutic strategy for Alzheimer's disease. Expert Review of Neurotherapeutics. 9: 1615-21 |